Trial Outcomes & Findings for Reperfusion With Cooling in Cerebral Acute Ischemia (NCT NCT01585597)

NCT ID: NCT01585597

Last Updated: 2014-08-01

Results Overview

Asymptomatic and symptomatic Hemorrhages defined as homogenous density occupying \>30% of the infarct zone with mass effect

Recruitment status

COMPLETED

Study phase

PHASE1

Target enrollment

20 participants

Primary outcome timeframe

24 Hours

Results posted on

2014-08-01

Participant Flow

Participant milestones

Participant milestones
Measure
Mild Hypothermia
Reduction of body temperature to 34 degrees centigrade. Zoll- Coolgaurd 3000: Goal temperature of 33 degrees Centigrade for a duration of 12 hours and then actively rewarmed by 0.2 degrees Centigrade per hour.
Overall Study
STARTED
20
Overall Study
COMPLETED
20
Overall Study
NOT COMPLETED
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Reperfusion With Cooling in Cerebral Acute Ischemia

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Mild Hypothermia
n=20 Participants
Reduction of body temperature to 34 degrees centigrade. Zoll- Coolgaurd 3000: Goal temperature of 33 degrees Centigrade for a duration of 12 hours and then actively rewarmed by 0.2 degrees Centigrade per hour.
Age, Continuous
59 years
STANDARD_DEVIATION 14 • n=5 Participants
Sex: Female, Male
Female
8 Participants
n=5 Participants
Sex: Female, Male
Male
12 Participants
n=5 Participants
Region of Enrollment
United States
20 participants
n=5 Participants

PRIMARY outcome

Timeframe: 24 Hours

Asymptomatic and symptomatic Hemorrhages defined as homogenous density occupying \>30% of the infarct zone with mass effect

Outcome measures

Outcome measures
Measure
Mild Hypothermia
n=20 Participants
Reduction of body temperature to 34 degrees centigrade. Zoll- Coolgaurd 3000: Goal temperature of 33 degrees Centigrade for a duration of 12 hours and then actively rewarmed by 0.2 degrees Centigrade per hour.
Number of Participants With Reperfusion Injury \ Hemorrhagic Transformation
3 participants

SECONDARY outcome

Timeframe: 90 days post hospitalization

Modified Rankin Score 0=no symptoms 1. no significant disability 2. slight disability needs help 3. moderate disability 4. moderate serve disability 5. severe disability 0-2 = good outcome 3-5= poor outcome

Outcome measures

Outcome measures
Measure
Mild Hypothermia
n=20 Participants
Reduction of body temperature to 34 degrees centigrade. Zoll- Coolgaurd 3000: Goal temperature of 33 degrees Centigrade for a duration of 12 hours and then actively rewarmed by 0.2 degrees Centigrade per hour.
Modified Rankin Scale 0-2
20 participants Modified Rankin Scal 0-2

Adverse Events

Mild Hypothermia

Serious events: 8 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Serious adverse events
Measure
Mild Hypothermia
n=20 participants at risk
Reduction of body temperature to 34 degrees centigrade. Zoll- Coolgaurd 3000: Goal temperature of 33 degrees Centigrade for a duration of 12 hours and then actively rewarmed by 0.2 degrees Centigrade per hour.
Infections and infestations
Pneumonia
25.0%
5/20 • Number of events 5 • 90 days
Infections and infestations
Bacteremia
5.0%
1/20 • Number of events 1 • 90 days
Blood and lymphatic system disorders
Deep Venous Thrombosis
5.0%
1/20 • Number of events 1 • 90 days
Infections and infestations
Urinary Tract Infection
20.0%
4/20 • Number of events 4 • 90 days

Other adverse events

Adverse event data not reported

Additional Information

Christopher Horn

Emory University

Phone: 404 387 7320

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place